Your browser doesn't support javascript.
loading
Extreme Interocular Asymmetry in an Atypical Case of a Hydroxychloroquine-Related Retinopathy.
Hallali, Gabriel; Seyed, Zari; Maillard, Anne-Véronique; Drine, Karima; Lamour, Laurence; Faure, Céline; Audo, Isabelle.
Afiliação
  • Hallali G; Ophthalmic Pediatric Unit, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 28 rue de Charenton, F-75012 Paris, France.
  • Seyed Z; Electrophysiology Unit, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 28 rue de Charenton, F-75012 Paris, France.
  • Maillard AV; Electrophysiology Unit, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 28 rue de Charenton, F-75012 Paris, France.
  • Drine K; Electrophysiology Unit, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 28 rue de Charenton, F-75012 Paris, France.
  • Lamour L; Electrophysiology Unit, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 28 rue de Charenton, F-75012 Paris, France.
  • Faure C; Electrophysiology Unit, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, 28 rue de Charenton, F-75012 Paris, France.
  • Audo I; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Centre de Référence Maladies Rares REFERET et DHU Sight Restore, INSERM-DGOS CIC1423, 28 rue de Charenton, F-75012 Paris, France.
Medicina (Kaunas) ; 58(7)2022 Jul 21.
Article em En | MEDLINE | ID: mdl-35888686
ABSTRACT
Background and

Objectives:

Long-term hydroxychloroquine (HCQ) therapy can lead to retinal toxicity. Typically, it is characterized by a bull's eye maculopathy. More recently, a "pericentral" form of HCQ retinopathy that predominantly affects patients of Asian descent has been described. To our knowledge, this is the first reported case where such an asymmetry between the right and the left eye in the toxicity profile is observed. Case presentation The patient presented with a 12-year exposure to HCQ at a daily dose of 4.35 mg/kg. She presented an inferior pericentral-only phenotype of HCQ toxicity on the right eye and a perifoveal-only toxicity on the left eye. Modest progression of toxicity was observed on both eyes over the seven years of follow-up, despite drug discontinuation.

Conclusions:

To our knowledge, this is the first time that two different phenotypes of HCQ-related retinopathy are found in the same patient, challenging our understanding of the pathophysiology of HCQ retinal toxicity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Antirreumáticos / Degeneração Macular Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Retinianas / Antirreumáticos / Degeneração Macular Idioma: En Ano de publicação: 2022 Tipo de documento: Article